JPH01148198A - Determination of sarcosine - Google Patents
Determination of sarcosineInfo
- Publication number
- JPH01148198A JPH01148198A JP30720287A JP30720287A JPH01148198A JP H01148198 A JPH01148198 A JP H01148198A JP 30720287 A JP30720287 A JP 30720287A JP 30720287 A JP30720287 A JP 30720287A JP H01148198 A JPH01148198 A JP H01148198A
- Authority
- JP
- Japan
- Prior art keywords
- sarcosine
- hydroxy
- reaction
- oxidase
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 title claims abstract description 48
- 108010077895 Sarcosine Proteins 0.000 title claims abstract description 24
- 229940043230 sarcosine Drugs 0.000 title claims abstract description 24
- 108010060059 Sarcosine Oxidase Proteins 0.000 claims abstract description 15
- 102000008118 Sarcosine oxidase Human genes 0.000 claims abstract description 15
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 8
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 3
- 150000001340 alkali metals Chemical group 0.000 claims abstract description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims abstract description 3
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 17
- 238000004040 coloring Methods 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 4
- 235000011330 Armoracia rusticana Nutrition 0.000 abstract description 2
- 240000003291 Armoracia rusticana Species 0.000 abstract description 2
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract description 2
- SYLPAUVHGVHMLB-UHFFFAOYSA-N 3-(n-ethyl-3-methoxyanilino)-2-hydroxypropane-1-sulfonic acid;sodium Chemical compound [Na].OS(=O)(=O)CC(O)CN(CC)C1=CC=CC(OC)=C1 SYLPAUVHGVHMLB-UHFFFAOYSA-N 0.000 abstract 1
- 238000004847 absorption spectroscopy Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 18
- 229940109239 creatinine Drugs 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 108010077078 Creatinase Proteins 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229960003624 creatine Drugs 0.000 description 3
- 239000006046 creatine Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- HXITYOAFXWBMLL-UHFFFAOYSA-N 3-(n-ethylanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC=CC=C1 HXITYOAFXWBMLL-UHFFFAOYSA-N 0.000 description 1
- 208000000659 Autoimmune lymphoproliferative syndrome Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 108010066906 Creatininase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940022682 acetone Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- MWFOPMKUGZLPQA-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCCN(CC)C1=CC=CC(OC)=C1 MWFOPMKUGZLPQA-UHFFFAOYSA-M 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000006016 thyroid dysfunction Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はサルコシンの定量法、更に詳細には、少ない酵
素量で短時間に精度よくサルコシンを定量する方法に関
する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for quantifying sarcosine, and more particularly, to a method for quantifying sarcosine in a short time and with high accuracy using a small amount of enzyme.
体液中のクレアチニンおよびクレアチンの定量は腎疾患
、筋肉疾患、甲状腺機能先進症等の診断のために重要で
ある。Quantification of creatinine and creatine in body fluids is important for diagnosis of renal diseases, muscle diseases, advanced thyroid dysfunction, etc.
従来よく用いられていたクレアチニンおよびクレアチン
の定量法はアルカリ性ピクリン酸を用いるヤツ7工法で
あるが、この方法はアセトン、ピルビン酸、葉酸等の他
の物質の影響を受けるため、正確なりレアチニンおよび
クレアチン量を求めることができないという欠点があっ
た。The commonly used method for quantifying creatinine and creatine is the method using alkaline picric acid, but this method is affected by other substances such as acetone, pyruvic acid, and folic acid, so it is not accurate. The drawback was that it was not possible to determine the quantity.
斯かる従来法の欠点を解決するために、クレアチニナー
ゼおよびクレアチナーゼを作用させてサルコシンを生成
させ、これにサルコシンオキシダーゼを作用させ、生成
する過酸化水素をペルオキシダーゼの存在下4−アミノ
アンチピリンとフェノール系又はアニリン系誘導体と反
応させて発色させてその吸光度を測定する酵素法が提案
された。In order to solve the drawbacks of the conventional method, sarcosine is produced by the action of creatininase and creatinase, which is then reacted with sarcosine oxidase, and the produced hydrogen peroxide is treated with 4-aminoantipyrine and phenol in the presence of peroxidase. An enzymatic method has been proposed in which the absorbance of the color is measured by reacting with an aniline derivative or an aniline derivative.
しかしながら、この酵素法も、従来の色素系を用いた場
合には、サルコシンから発色体を得るまでの反応が遅く
、そのため多量の酵素を必要とすると共に、血清中の妨
害因子の影響を受は易いという欠点があった。However, when this enzymatic method uses a conventional dye system, the reaction from sarcosine to the chromophore is slow, requires a large amount of enzyme, and is not affected by interfering factors in serum. It had the disadvantage of being easy.
従って、サルコシンを少ない酵素量で短時間に定量する
方法の提供が望まれていた。Therefore, it has been desired to provide a method for quantifying sarcosine in a short time using a small amount of enzyme.
斯かる実状において、本発明者は鋭意研究を行った結果
、色原体として4−アミノアンチピリンと後記一般式(
I)で表わされるN−2−ヒドロキシ−3−スルホプロ
ピルアニリン誘導体(以下、AO3と称する)ft使用
すると、AO8がサルコシンオキシダーゼのサルコシン
に対するミカエリス定数(Km値)を著しく増大し、少
ない酵素量で短時間にサルコシンを定量できることを見
出し、本発明を完成したO
すなわち、本発明は、サルコシン含有試料にサルコシン
オキシメーゼ、ペルオΦシダ−ゼ、4−アミノアンチピ
リンおよび一般式(4)(式中、Rは水素原子又はメト
キシ基を、Mはアルカリ金属を示す)
テ表ワサれるN−2−ヒドロキシ−3−スル、ホプロピ
ルアニリン誘導体を作用させ、生ずる発色体を測定する
ことを特徴とするサルコシンの定量法を提供するもので
ある。Under such circumstances, the present inventor conducted intensive research and found that 4-aminoantipyrine and the general formula (
When the N-2-hydroxy-3-sulfopropylaniline derivative (hereinafter referred to as AO3) ft represented by I) is used, AO8 significantly increases the Michaelis constant (Km value) of sarcosine oxidase for sarcosine, and even with a small amount of enzyme. The present invention has been completed by discovering that sarcosine can be quantified in a short period of time. That is, the present invention is based on the present invention. , R represents a hydrogen atom or a methoxy group, and M represents an alkali metal). This provides a method for quantifying sarcosine.
本発明の定量法はサルコシンを含有する全ての試料に適
用することができ、サルコシン含有液またはサルコシン
を遊離する反応系から生ずるサルコシン含有液、例えば
クレアチニンまたはクレアチ/を含有する体液にクレア
チニナーゼおよびクレアチナーゼを作用させて得られる
試料等が挙げられる。The quantitative method of the present invention can be applied to all samples containing sarcosine. Examples include samples obtained by the action of creatinase.
本発明に使用するサルコシンオキシダーゼはいかなる起
源のものでもよいが、例えばコリネバクテリウム属、フ
ラボバクテリウム属、バチルス属等に属する微生物が産
生ずるものが挙げられ、その使用量は5〜30 U /
test 。The sarcosine oxidase used in the present invention may be of any origin, but examples include those produced by microorganisms belonging to the genus Corynebacterium, Flavobacterium, Bacillus, etc., and the amount used is 5 to 30 U /
test.
特に10〜20 U / testが好ましい。また、
ペルオキシダーゼも1動植物、微生物等のいかなる起源
のものでもよいが、特に西洋ワサビ由来のペルオキシダ
ーゼが好ましく、その使用量は05〜5 U / te
st 、特に1〜2U/l@mtが好ましい。Particularly preferred is 10-20 U/test. Also,
Peroxidase may be of any origin, such as animals, plants, microorganisms, etc., but peroxidase derived from horseradish is particularly preferred, and the amount used is 0.5 to 5 U/te.
st, especially 1 to 2 U/l@mt.
本発明の色原体の1つであるAO8の好ましいものとし
ては、例えばソゾウムーN−エチに−N−(2−ヒドロ
キシ−3−スルホゾロピル)メタアニシジン(^DO8
と称する)、ンゾウムーN−エチル−N−(2−ヒドロ
キシ−3−スルホゾロぎル)アニIJ ン(AlO2と
称する)等が挙げられる。これらのAO8は試料に対し
001〜1 v / v%の範囲になるように使用する
のが好ましい。Preferred examples of AO8, which is one of the chromogens of the present invention, include -N-(2-hydroxy-3-sulfozolopyl)methanisidine (^DO8
(referred to as AlO2), N-ethyl-N-(2-hydroxy-3-sulfozologyl)aniline (referred to as AlO2), and the like. These AO8s are preferably used in a range of 001 to 1 v/v% relative to the sample.
本発明の定量法は、色原体の1つとしてAO8ft使用
する以外は公知の方法によって行うことができる。測定
系のpHは発色体の呈色の安定範囲内であればよく、例
えばADO8の場合にはpHa5〜Q5、AlO2の場
合にはp)I e、 5〜75が好ましい。緩衝液はこ
のpH範囲のものであれば何れのものでもよく、例えば
リン酸緩衝液、トリス緩衝液等が使用される。The quantitative method of the present invention can be carried out by a known method except for using AO8ft as one of the chromogens. The pH of the measurement system may be within the stable range of color development of the color former, and for example, in the case of ADO8, pHa5 to Q5, and in the case of AlO2, p)Ie, is preferably 5 to 75. Any buffer may be used as long as it has a pH within this range; for example, phosphate buffer, Tris buffer, etc. are used.
このようKすると、 AO8と4−アミノアンチピリン
は過酸化水素の存在で酸化縮合して発色体を生成するの
で、例えば、 ADO8の場合には542 nmで、人
LO8の場合には565nmにて吸光度を測定すればサ
ルコシン量を定量することができる。When K is applied in this manner, AO8 and 4-aminoantipyrine undergo oxidative condensation in the presence of hydrogen peroxide to produce a chromophore, so for example, the absorbance at 542 nm for ADO8 and 565 nm for human LO8. The amount of sarcosine can be determined by measuring.
斜上の如く、本発明によれば、色原体のAO8がサルコ
シンからの過酸化水素生成反応を促進するので、少ない
酵素量で短時間にサルコシンの定量を行うことができる
。而して、体液中のクレアチニンおよびクレアチンの定
量においては、サルコシンからの過酸化水素生成反応が
律速反応であるから、この反応を短時間で行うことので
きる本発明は臨床検査の診断分野において極めて有意義
である。As shown above, according to the present invention, since the chromogen AO8 promotes the hydrogen peroxide production reaction from sarcosine, sarcosine can be quantified in a short time with a small amount of enzyme. In quantifying creatinine and creatine in body fluids, the hydrogen peroxide production reaction from sarcosine is the rate-limiting reaction, so the present invention, which can perform this reaction in a short time, is extremely useful in the diagnostic field of clinical tests. Meaningful.
次に実施例を挙げて本発明を説明する。 Next, the present invention will be explained with reference to Examples.
実施例1
サルコシンの定量・・・・・・各種色原体の比較:反応
液組成
リン酸緩衝液 40 mM 、 p
HEL 04−アミノアンチピリン(4−^A)
0.02%ペルオキシダーゼ 2.5
U色原体 002%サルコシン
Q l pmo l e上記反応
液0.5 dに各量のサルコシンオキシダーゼを添加し
、37℃にて5分間反応させた後、05%SDS溶液1
d tl″加えて反応を停止し、各色原体の吸収波長
にて吸光度を測定した。測定結果を第1図に示す。Example 1 Quantification of sarcosine... Comparison of various chromogens: Reaction solution composition Phosphate buffer 40 mM, p
HEL 04-aminoantipyrine (4-^A)
0.02% peroxidase 2.5
U Chromogen 002% Sarcosine Q l pmol e Add each amount of sarcosine oxidase to 0.5 d of the above reaction solution, react for 5 minutes at 37°C, and then add 0.5% SDS solution 1
d tl'' was added to stop the reaction, and the absorbance was measured at the absorption wavelength of each chromogen. The measurement results are shown in FIG.
これよシ明らかな如く、ADO8、AlO2の2種のみ
が他の色原体と比較して少ない酵素量で短時間に反応が
終了しておシ、良好な結果を示した。As is clear from this, only two chromogens, ADO8 and AlO2, showed good results as the reaction was completed in a short time with a small amount of enzyme compared to other chromogens.
尚色原体としては次のものを使用した。The following chromogens were used.
ADO8:ソゾウムーN−エチルーN−(2−ヒドロキ
シ−3−スルホプロピル)
メタアニシジン
AlO2:ソゾウムーN−エチルーN−(2−ヒドロキ
シ−3−スルホゾロビル)
アニリン
TOO8:ソゾウムーN−エチルーN−(2−ヒドロキ
シ−3−スルホプロピル)
メタトルイゾン
ALPS ;ソゾウムーN−エチルーN−スルホプロピ
ル−アニリン
ADPS :ソゾウムーN−エチルーN−スルホゾロビ
ルーメタアニシゾン
DAO8:ソシウムーN−エチルーN−(2−ヒドロキ
シ−3−スルホゾロビル)
−3,5−ジメトキシアニリン
HDAPS :ソゾウムーN−スルホゾロビルー3.5
−ジメトキシアニリン
PN:フェノール
DE人=ゾメチルアニリン
実施例2
ADO8’i用いた発色系におけるサルコシンオキシダ
ーゼのKm値:
反応液組成
リン酸緩衝液 40mM 、 pHa。ADO8: Sozoum N-ethyl N-(2-hydroxy-3-sulfopropyl) Meta-anisidine AlO2: Sozoum N-ethyl N-(2-hydroxy-3-sulfozolovir) Aniline TOO8: Sozoum N-ethyl N-(2-hydroxy- 3-sulfopropyl) metatoluizone ALPS; Sozoum N-ethyl-N-sulfopropyl-aniline ADPS: Sozoum N-ethyl N-sulfozolobyl-metaanisizone DAO8: Sozoum N-ethyl N-(2-hydroxy-3-sulfozolovir) - 3,5-dimethoxyaniline HDAPS: Sozoum N-sulfozolobyl-3.5
-Dimethoxyaniline PN: Phenol DE Human = Zomethylaniline Example 2 Km value of sarcosine oxidase in coloring system using ADO8'i: Reaction solution composition Phosphate buffer 40mM, pHa.
4−ムA 002%色原体
0.02%ペルオキシダーゼ
2.5Uサルコシンオキシダーゼ 12.5m
U上記反応液05mに各濃度のサルコシンを添加し、3
7℃にて5分間反応させた後、05%SO8溶液1−を
加えて反応を停止し、各々の吸光度を測定した。結果を
第2図に示す。第2図よりLineveaver−Bu
rkプロットによシ求めたKm値は、対照の4−AA
−フェノールの発色系におけるサルコシンオキシダーゼ
のKm値が67:OmMであるのに対し、 4−AA−
ADO8の発色系におけるサルコシンオキシダーゼのK
m値は131 mMであった。すなわチ、サルコシンオ
キシダーゼのサルコシンに対するKm値は、4−AA−
ADO8の発色系を用いた場合、4−AA−フェノール
の発色系と比較して約5分の1に低下していた。4-muA 002% chromogen
0.02% peroxidase
2.5U Sarcosine Oxidase 12.5m
Add sarcosine at various concentrations to 05m of the above reaction solution, and add 3
After reacting at 7°C for 5 minutes, 05% SO8 solution 1- was added to stop the reaction, and the absorbance of each was measured. The results are shown in Figure 2. From Figure 2, Lineveaver-Bu
The Km value determined by the rk plot is the same as that of the control 4-AA.
-The Km value of sarcosine oxidase in the phenol coloring system is 67:OmM, whereas 4-AA-
K of sarcosine oxidase in ADO8 color system
m value was 131 mM. In other words, the Km value of sarcosine oxidase for sarcosine is 4-AA-
When the ADO8 coloring system was used, it was reduced to about one-fifth compared to the 4-AA-phenol coloring system.
実施例3
ADO8を用いたクレアチニンの定量・・・用時間経過
:
反応液組成
リン酸緩衝液 40mM 、 pH
a。Example 3 Quantification of creatinine using ADO8 Time course: Reaction solution composition Phosphate buffer 40mM, pH
a.
4−AA QO2%ADO
8002%
ペルオキシダーゼ 25Uクレアチニナー
ゼ IOUクレアチナーゼ
20Uサルコシンオキシダーゼ 20U上
記反応液0.5 wlにクレアチニンをlOnmo 1
@添加し、37℃にて542 amの吸光度変化を測
定した。結果を第3図に示す。これよ多明らかな如く、
反応は5分で完全に終了してお〕、良好な結果を得た。4-AA QO2%ADO
8002% Peroxidase 25U Creatinase IOU Creatinase
20U sarcosine oxidase 20U Add creatinine to 0.5 wl of the above reaction solution Onmo 1
@ was added, and the change in absorbance at 542 am was measured at 37°C. The results are shown in Figure 3. As is obvious,
The reaction was completely completed in 5 minutes] and good results were obtained.
実施例4
ADO8を用いたクレアチニンの定量・・・・・・検量
線:
実施例2における反応液05m1に各量のクレアチニン
を加え、37℃にて5分間反応させた後、542nmの
吸光度を測定した。結果は第4図に示すとおシであシ、
極めて良好な直線性を示した。Example 4 Quantification of creatinine using ADO8 Calibration curve: Add each amount of creatinine to 05 ml of the reaction solution in Example 2, react at 37°C for 5 minutes, and then measure the absorbance at 542 nm. did. The results are shown in Figure 4.
It showed extremely good linearity.
第1図は各種色原体を用いたときの吸光度とサルコシン
オキシダーゼ量との関係を示す図、第2図はADO8を
用いた発色系及びフエ/−ルf用いた発色系におけるサ
ルコシンオキシダーゼの基質飽和曲線を示す図、第3図
はクレアチニンの定量において、色原体としてADO8
を用いたときの吸光度の経時変化を示す図、第4図は色
原体としてADO8を用いてクレアチニンを定量すると
きの検量線を示す図である。
以上
一ノFigure 1 shows the relationship between the absorbance and the amount of sarcosine oxidase when using various chromogens. Figure 2 shows the substrate for sarcosine oxidase in the coloring system using ADO8 and the coloring system using Fe/-F. A diagram showing a saturation curve, Figure 3 shows the use of ADO8 as a chromogen in the determination of creatinine.
Figure 4 is a diagram showing the change in absorbance over time when using ADO8 as a chromogen, and Figure 4 is a diagram showing a calibration curve when quantifying creatinine using ADO8 as a chromogen. That's all
Claims (1)
ルオキシダーゼ、4−アミノアンチピリンおよび一般式
( I ) ▲数式、化学式、表等があります▼( I ) (式中、Rは水素原子又はメトキシ基を、Mはアルカリ
金属を示す) で表わされるN−2−ヒドロキシ−3−スルホプロピル
アニリン誘導体を作用させ、生ずる発色体を測定するこ
とを特徴とするサルコシンの定量法。[Claims] 1. Sarcosine-containing samples include sarcosine oxidase, peroxidase, 4-aminoantipyrine, and the general formula (I) ▲ Numerical formula, chemical formula, table, etc. ▼ (I) (In the formula, R is a hydrogen atom or methoxy A method for quantifying sarcosine, which comprises reacting with an N-2-hydroxy-3-sulfopropylaniline derivative represented by the following formula (M represents an alkali metal) and measuring the resulting colored product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30720287A JPH01148198A (en) | 1987-12-04 | 1987-12-04 | Determination of sarcosine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30720287A JPH01148198A (en) | 1987-12-04 | 1987-12-04 | Determination of sarcosine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01148198A true JPH01148198A (en) | 1989-06-09 |
Family
ID=17966269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30720287A Pending JPH01148198A (en) | 1987-12-04 | 1987-12-04 | Determination of sarcosine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01148198A (en) |
-
1987
- 1987-12-04 JP JP30720287A patent/JPH01148198A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3979262A (en) | Compositions and methods for the determination of oxidizing agents | |
JPH0470000B2 (en) | ||
JPS5886083A (en) | Stabilizing agent for glycerol-3-phosphoric acid oxidase | |
US3558435A (en) | Diagnostic agents for use in the determination of hydroperoxides and of peroxidate-active substances and methods for manufacturing and using the same | |
JPS63182000A (en) | Measurement of creatine or creatinine and reagent therefor | |
JPS5819279B2 (en) | Method and reagent for measuring NAD(P)H or salicylate | |
Watts | Determination of uric acid in blood and in urine | |
US3349006A (en) | Process and composition for the enzymatic determination of uric acid | |
Reljic et al. | New chromogen for assay of glucose in serum | |
JPH0571239B2 (en) | ||
US5266472A (en) | Stabilization of the enzyme urate oxidase in liquid form | |
Asp | Improved method for the assay of phenylglycosidase activity with a 4-aminoantipyrine reagent | |
JPH08298997A (en) | Inhibition of activity of reducing substance on oxidatively color-developing analysis | |
JPH01148198A (en) | Determination of sarcosine | |
Kamoun et al. | Ultramicromethod for determination of plasma uric acid. | |
Kuan et al. | An alternative method for the determination of uric acid in serum | |
JPS603480B2 (en) | Creatinine and creatine determination method | |
US5888828A (en) | Kit for measuring urea nitrogen | |
Rindfrey et al. | Kinetic determination of glucose concentrations with glucose dehydrogenase | |
JPH03175997A (en) | Determination of total bilirubin and reagent used therefor | |
JPH01112155A (en) | Method for determination of hydrogen peroxide and reagent for said determination | |
JPH03164198A (en) | Analysis of component | |
US4722894A (en) | Method for the determination of ceruloplasmin activity | |
US4727025A (en) | Process and reagent for the fully enzymatic determination of urea | |
JPH03206896A (en) | Determination of very small amount component in body fluid |